HealthEquity (HQY) is expected to deliver "meaningful" long-term earnings growth despite upcoming US Federal Reserve rate cuts, RBC Capital Markets said in a note Thursday.
"Despite reaccelerating fundamentals, HealthEquity's valuation has steadily compressed of late, primarily on concerns around its exposure/sensitivity to interest rates and the forthcoming Fed cutting cycle," RBC said.
The investment firm said increasing custodial yields are set to provide strong tailwinds over the next three years, potentially driving HealthEquity's earnings per share growth to exceed 20% annually through 2027 "even with a 75 to 100 basis-point surprise shift in the forward curve," according to the note.
HealthEquity's health savings account growth is projected at 7% to 7.5% through 2027, driven by rising medical cost trends and "loosening" labor markets, RBC said.
RBC raised its price target on HealthEquity stock to $100 from $92 and maintained its outperform rating.
Shares of HealthEquity rose 1.2% in recent trading.
Price: 78.43, Change: +0.89, Percent Change: +1.15
Comments